State of Michigan Retirement System lowered its position in HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 5.6% during the fourth quarter, according to its most recent filing with the SEC. The firm owned 41,809 shares of the company's stock after selling 2,500 shares during the period. State of Michigan Retirement System's holdings in HCA Healthcare were worth $19,519,000 as of its most recent filing with the SEC.
Several other large investors also recently modified their holdings of HCA. Viking Global Investors LP grew its position in shares of HCA Healthcare by 58.5% during the 2nd quarter. Viking Global Investors LP now owns 1,872,133 shares of the company's stock worth $717,214,000 after buying an additional 690,773 shares during the period. Danske Bank A S acquired a new position in HCA Healthcare during the 3rd quarter worth approximately $115,530,000. Zurich Insurance Group Ltd FI raised its stake in HCA Healthcare by 3,755.9% during the 3rd quarter. Zurich Insurance Group Ltd FI now owns 269,912 shares of the company's stock worth $115,036,000 after buying an additional 262,912 shares during the period. Mondrian Investment Partners LTD acquired a new position in shares of HCA Healthcare during the third quarter worth approximately $106,605,000. Finally, Public Sector Pension Investment Board lifted its holdings in shares of HCA Healthcare by 127.3% in the 3rd quarter. Public Sector Pension Investment Board now owns 369,704 shares of the company's stock worth $157,568,000 after purchasing an additional 207,070 shares in the last quarter. Institutional investors and hedge funds own 62.73% of the company's stock.
Wall Street Analysts Forecast Growth
A number of brokerages recently issued reports on HCA. Truist Financial cut their target price on HCA Healthcare from $546.00 to $535.00 and set a "buy" rating on the stock in a report on Monday. Weiss Ratings reiterated a "buy (b)" rating on shares of HCA Healthcare in a report on Friday, March 27th. Stephens lowered their price objective on HCA Healthcare from $560.00 to $530.00 and set an "overweight" rating for the company in a research note on Monday. The Goldman Sachs Group increased their price objective on HCA Healthcare from $520.00 to $558.00 and gave the stock a "buy" rating in a research note on Wednesday, January 28th. Finally, Mizuho increased their price objective on HCA Healthcare from $540.00 to $585.00 and gave the stock an "outperform" rating in a research note on Wednesday, February 25th. Sixteen analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat, the stock presently has an average rating of "Moderate Buy" and a consensus price target of $523.09.
Check Out Our Latest Research Report on HCA
HCA Healthcare Stock Up 3.2%
Shares of NYSE HCA opened at $446.38 on Tuesday. HCA Healthcare, Inc. has a twelve month low of $326.14 and a twelve month high of $556.52. The stock's 50 day moving average price is $503.58 and its 200-day moving average price is $486.01. The company has a market capitalization of $99.80 billion, a PE ratio of 15.35, a PEG ratio of 1.45 and a beta of 1.36.
HCA Healthcare (NYSE:HCA - Get Free Report) last announced its earnings results on Friday, April 24th. The company reported $7.15 earnings per share (EPS) for the quarter, missing the consensus estimate of $7.19 by ($0.04). HCA Healthcare had a net margin of 8.89% and a negative return on equity of 295.93%. The business had revenue of $19.11 billion for the quarter, compared to analysts' expectations of $19.09 billion. During the same period in the prior year, the business earned $6.45 earnings per share. The company's revenue for the quarter was up 4.3% compared to the same quarter last year. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. As a group, research analysts expect that HCA Healthcare, Inc. will post 30.15 EPS for the current fiscal year.
HCA Healthcare Dividend Announcement
The firm also recently announced a quarterly dividend, which will be paid on Tuesday, June 30th. Stockholders of record on Tuesday, June 16th will be given a dividend of $0.78 per share. The ex-dividend date of this dividend is Tuesday, June 16th. This represents a $3.12 annualized dividend and a dividend yield of 0.7%. HCA Healthcare's dividend payout ratio (DPR) is currently 10.73%.
Key Headlines Impacting HCA Healthcare
Here are the key news stories impacting HCA Healthcare this week:
- Positive Sentiment: Management reaffirmed FY2026 guidance and expects 2%–3% volume growth while acknowledging headwinds, which supports the company’s forward earnings outlook. HCA projects 2%-3% volume growth
- Positive Sentiment: HCA says improvements in its revenue‑cycle operations are boosting cash collections and helping offset rising denials/underpayments — a near‑term margin and cash‑flow positive. Revenue cycle paying dividends
- Positive Sentiment: Leadership hire: Cynthia Cifuentes‑Finkel will become SVP of Marketing & Corporate Affairs (effective June 8), adding senior marketing/communications capacity ahead of growth initiatives. HCA names new SVP
- Neutral Sentiment: Local operations: a new HCA Florida Gainesville hospital is preparing to open next month — incremental local growth but limited immediate impact on enterprise results. Gainesville hospital opening
- Neutral Sentiment: Market commentary pieces and index signals are discussing healthcare positioning; useful for macro context but not company‑specific catalysts. Market update
- Negative Sentiment: Multiple analysts reduced price targets and trimmed forecasts after Q1 results (despite an in‑line EPS), signaling more cautious near‑term sentiment. Firms lowering targets include Stephens, Oppenheimer, TD Cowen, Leerink, RBC and Truist. Analysts slash forecasts
- Negative Sentiment: Q1 dynamics: EPS roughly in‑line but seasonal volume softness, shifting payer mix and projected ACA/exchange pressures (company cites a $600M–$900M headwind range) are weighing on near‑term revenue and margin expectations. Q1 deep dive
- Negative Sentiment: Financing: HCA filed a proposed public offering of senior notes to raise proceeds for general corporate purposes (may include refinancing). New debt issuance could modestly pressure credit metrics depending on size and terms. Proposed senior notes offering
Insider Activity at HCA Healthcare
In other news, SVP Jennifer Berres sold 8,020 shares of the firm's stock in a transaction that occurred on Wednesday, February 11th. The shares were sold at an average price of $514.58, for a total transaction of $4,126,931.60. Following the completion of the sale, the senior vice president owned 11,993 shares in the company, valued at $6,171,357.94. This trade represents a 40.07% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, SVP Christopher F. Wyatt sold 4,000 shares of the firm's stock in a transaction that occurred on Wednesday, February 11th. The stock was sold at an average price of $505.00, for a total transaction of $2,020,000.00. Following the sale, the senior vice president owned 44,379 shares of the company's stock, valued at approximately $22,411,395. The trade was a 8.27% decrease in their position. The disclosure for this sale is available in the SEC filing. In the last 90 days, insiders have sold 15,214 shares of company stock worth $7,797,595. 1.50% of the stock is currently owned by company insiders.
HCA Healthcare Company Profile
(
Free Report)
HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.
The company's core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA's services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.
Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider HCA Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and HCA Healthcare wasn't on the list.
While HCA Healthcare currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.
Get This Free Report